<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xhtml="http://www.w3.org/1999/xhtml">
  <url>
    <loc>https://regeltherapeutics.com/news-articles</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-09-30</lastmod>
  </url>
  <url>
    <loc>https://regeltherapeutics.com/news-articles/scn2a</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-09-17</lastmod>
  </url>
  <url>
    <loc>https://regeltherapeutics.com/news-articles/regel-therapeutics-appoints-stephen-j-farr-as-new-chief-executive-officer</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-09-17</lastmod>
  </url>
  <url>
    <loc>https://regeltherapeutics.com/news-articles/regel-therapeutics-awarded-1-million-from-hs-chau-women-in-enterprising-science-program-at-the-innovative-genomics-institute-to-continue-developing-its-gene-modulation-technology</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-09-17</lastmod>
  </url>
  <url>
    <loc>https://regeltherapeutics.com/news-articles/regel-therapeutics-announces-its-participation-at-the-dravet-syndrome-conference-and-attendance-at-the-european-dravet-syndrome-advanced-therapies-meeting-in-madrid-spain-on-march-23rd-and-24th-2023</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-09-17</lastmod>
  </url>
  <url>
    <loc>https://regeltherapeutics.com/news-articles/regel-therapeutics-details-its-proprietary-t3-platform-and-development-pipeline-on-its-newly-launched-website-expands-its-board-of-directors-and-announces-its-scientific-advisory-board</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2025-08-11</lastmod>
  </url>
  <url>
    <loc>https://regeltherapeutics.com/home</loc>
    <changefreq>daily</changefreq>
    <priority>1.0</priority>
    <lastmod>2025-08-14</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/68812cbcb2763d6e7501f6d9/e35aac65-746c-4295-b7a4-20ea0877faf1/rglt.preview.0001+%284%29_1.png</image:loc>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/68812cbcb2763d6e7501f6d9/7af3501d-a547-4581-bf25-17dace1707b7/RegelTherapeutics_Full_BW.png</image:loc>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/68812cbcb2763d6e7501f6d9/81632e77-0835-4638-b2f4-41ce69b34000/AAV_1.png</image:loc>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/624b503b5190ea02985eedb4/1649102921405-9XL7O1A0DDR2HFAQG7M5/Stocksy_txp9c995bd1cMI100_Large_1188910.jpg</image:loc>
      <image:title>Regel Therapeutics</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://regeltherapeutics.com/news</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2025-08-11</lastmod>
  </url>
</urlset>

